Sign up to save your podcasts
Or
Share Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks.
Show reference:
https://www.neurology.org/doi/10.1212/NXI.0000000000200211
View all episodes
By American Academy of Neurology
4.8
129129 ratings
Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks.
Show reference:
https://www.neurology.org/doi/10.1212/NXI.0000000000200211
More shows like Neurology Minute
View all
JAMA Editors' Summary
130 Listeners
Neurology® Podcast
288 Listeners
NEJM This Week
324 Listeners
Practical Neurology Podcast
45 Listeners
JAMA Clinical Reviews
492 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
87 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
185 Listeners
Navigating Neuropsychology
340 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
348 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
366 Listeners
Continuum Audio
78 Listeners